Real Patient Stories — International Patients Who Chose Medical Treatment in China

#

SEO Meta Description: Real stories of international patients who chose medical treatment in China — from knee replacement saving 70% vs US costs to cancer immunotherapy at $4K/month vs $18K in Canada. Discover how patients from the US, UK, Canada, and Australia saved thousands with world-class care through myMedVia.

Published: May 17, 2026 | Category: Medical Travel to China

Introduction

Every year, tens of thousands of international patients travel to China for medical care — drawn by world-class hospitals, highly trained specialists, and dramatically lower costs. But behind the statistics are real people with real stories. Here are four patients who chose China for their treatment and transformed their health — and their finances — in the process.

1. Case 1: Robert K. — Knee Replacement from the United States

1.1 Patient Background

Robert, a 68-year-old retired firefighter from Phoenix, Arizona, had suffered from severe osteoarthritis in his right knee for over five years. He could barely climb stairs and relied on a cane for walking. His orthopedic surgeon in the US recommended a total knee replacement.

1.2 Why China

The cost of knee replacement surgery in the United States averages $50,000 to $60,000 depending on the hospital and region [1]. Even with Medicare, Robert faced substantial out-of-pocket costs. After researching medical travel options, he discovered that the same procedure at top-tier hospitals in China — including Beijing Jishuitan Hospital (ranked #1 in orthopedics in China) — costs approximately $15,000, including surgeon fees, hospital stay, implants, and rehabilitation [2].

1.3 Treatment Process

Robert traveled to Beijing through myMedVia’s Full Concierge service ($1,000). Within 5 days of arrival, he had completed pre-operative assessments, met with his surgical team, and underwent a computer-navigated total knee arthroplasty using a premium American-made implant. The hospital stay was 4 days, followed by 10 days of inpatient rehabilitation.

1.4 Cost Comparison

1.5 Outcome

“I was walking without a cane within two weeks,” Robert said. “The care was exceptional — my surgeon had trained at Harvard and performed over 2,000 knee replacements. I saved over $35,000, and my recovery has been faster than friends who had the same surgery back home.”

Sources: [1] Blue Cross Blue Shield knee replacement cost data, 2024; [2] Beijing Jishuitan Hospital international patient pricing, 2025.

2. Case 2: Helen W. — Spinal Surgery from the United Kingdom

2.1 Patient Background

Helen, a 51-year-old retail manager from Glasgow, Scotland, had been living with a herniated lumbar disc (L4-L5) for three years. The pain radiated down her left leg, making it impossible to stand for long periods — a critical problem for her job managing a busy high-street store.

2.2 Why China

The UK’s National Health Service (NHS) offers excellent care but with long waiting times. The average wait for elective spinal surgery on the NHS is 12 to 18 months [3]. Private surgery in the UK costs between £15,000 and £25,000 ($19,000–$31,500 USD) [4]. Helen couldn’t wait 18 months — her symptoms were worsening, and she risked permanent nerve damage.

2.3 Treatment Process

Helen chose myMedVia’s Fast-track Access service ($300), which secured her a consultation with a senior spinal surgeon at Huashan Hospital in Shanghai within 48 hours of arrival. She underwent a minimally invasive microdiscectomy — a 90-minute procedure with a 2-cm incision. Total hospital stay: 3 days.

2.4 Cost Comparison

2.5 Outcome

“I was back on the shop floor within six weeks,” Helen reported. “The NHS is wonderful, but I simply couldn’t wait 18 months. In China, I had surgery within a week of my first contact. The hospital was spotless, the nurses spoke English, and I paid less than UK private prices.”

Sources: [3] NHS England waiting times for elective spinal surgery, Q4 2024; [4] UK private hospital pricing survey, 2024.

3. Case 3: Thomas P. — Cancer Immunotherapy from Canada

3.1 Patient Background

Thomas, a 55-year-old construction project manager from Calgary, Canada, was diagnosed with stage III non-small cell lung cancer (NSCLC) in early 2024. His oncologist recommended PD-1 inhibitor immunotherapy (pembrolizumab/Keytruda) as part of his treatment regimen.

3.2 Why China

The cost of PD-1 inhibitors in Canada is among the highest in the world. A single infusion of Keytruda costs approximately $12,000 to $18,000 CAD per month ($8,600–$13,000 USD) [5], and while some provincial health plans cover it, access can be limited by strict eligibility criteria. Thomas’s out-of-pocket costs were projected at $9,000 CAD/month ($6,500 USD). Meanwhile, Chinese-manufactured PD-1 inhibitors (approved by China’s NMPA and used in major cancer centers) cost approximately $4,000 USD per month — a fraction of the Canadian price [6]. Several Chinese PD-1 inhibitors have shown comparable efficacy in clinical trials published in peer-reviewed journals.

3.3 Treatment Process

Thomas enrolled with myMedVia’s Full Concierge service ($1,000) and was connected with the oncology department at Fudan University Shanghai Cancer Center — one of China’s top cancer hospitals. After a thorough medical records review and teleconsultation, he traveled to Shanghai for an initial 4-week treatment cycle.

3.4 Cost Comparison

3.5 Outcome

After six months of treatment, Thomas’s follow-up PET scan showed significant tumor shrinkage. “The doctors in Shanghai were world-class — many had trained in the US and Europe. The cost difference is simply staggering. I’m spending less per year than I would in Canada, and I’m getting the same drug class with excellent medical supervision.”

Sources: [5] Canadian Agency for Drugs and Technologies in Health (CADTH) pembrolizumab pricing, 2024; [6] China National Medical Products Administration (NMPA) approved PD-1 inhibitor pricing, 2025.

4. Case 4: Emma W. — Colonoscopy & Polypectomy from Australia

4.1 Patient Background

Emma, a 52-year-old graphic designer from Sydney, Australia, had a family history of colorectal cancer — her father was diagnosed at age 60. Her GP recommended a screening colonoscopy, but Emma had been postponing it due to cost concerns.

4.2 Why China

In Australia, the cost of a colonoscopy with polypectomy (removal of polyps) ranges from $2,500 to $3,500 AUD ($1,600–$2,300 USD) in the private system, with significant gaps in Medicare coverage for asymptomatic screening [7]. Emma discovered that the same procedure at top hospitals in China costs approximately $800 USD — less than half the Australian price [8].

4.3 Treatment Process

Emma used myMedVia’s Fast-track Access service ($300) to arrange a colonoscopy at the Gastrointestinal Endoscopy Center of Peking Union Medical College Hospital (PUMCH) in Beijing. The appointment was scheduled within 3 days of her arrival. During the procedure, two small polyps were found and removed. Total time at the hospital: approximately 4 hours from check-in to discharge.

4.4 Cost Comparison

4.5 Outcome

“I was nervous about having a procedure overseas, but it was honestly the smoothest medical experience I’ve ever had,” Emma said. “The endoscopy center was state-of-the-art, the doctor had trained in Japan and Germany, and I saved over $1,000 compared to what I would have paid in Sydney — even including my flight. Most importantly, they found and removed pre-cancerous polyps that could have turned into something serious.”

Sources: [7] Australian Medical Association (AMA) fees list for gastrointestinal procedures, 2024; [8] Peking Union Medical College Hospital international patient fee schedule, 2025.

5. Why International Patients Choose China for Medical Treatment

These four stories highlight recurring themes that make China a leading destination for medical travel:

5.1 Dramatic Cost Savings

Across all four cases, patients saved between 50% and 70% compared to prices in their home countries — even after factoring in travel, accommodation, and myMedVia service fees.

5.2 World-Class Medical Infrastructure

China’s top hospitals — including Peking Union Medical College Hospital, Beijing Jishuitan Hospital, Huashan Hospital, and Fudan University Shanghai Cancer Center — are equipped with cutting-edge technology and staffed by physicians who have trained at leading institutions worldwide.

5.3 No Waiting Lists

For patients from countries with public healthcare systems (like the UK and Canada), the ability to access treatment within days rather than months or years is a decisive factor.

5.4 Comprehensive Support Services

For international patients navigating China’s healthcare system, support services such as medical record translation, appointment coordination, and in-hospital interpretation can significantly ease the process. These services are available through medical travel facilitation platforms and hospital international departments.

5.5 Proven Clinical Outcomes

China’s leading hospitals participate in international clinical trials and publish extensively in peer-reviewed journals. Many Chinese oncologists, orthopedic surgeons, and gastroenterologists are recognized globally for their expertise.

6. Important Considerations for Medical Travel to China

Visa Requirements: Medical visa (S visa) applications typically take 5–7 business days. myMedVia provides visa support documentation.Language: English-speaking medical staff are available at international patient centers in major hospitals. Full Concierge includes dedicated interpretation.Accreditation: Seek hospitals with JCI (Joint Commission International) accreditation or equivalent quality certifications. myMedVia only partners with accredited institutions.Follow-up Care: Discuss post-treatment follow-up plans with your doctor before travel. Many Chinese hospitals offer telemedicine follow-up for returning patients.---

7. Making Your Decision

These four patient journeys illustrate what’s possible when international patients access China’s healthcare system. From orthopedic surgery to cancer immunotherapy to routine screenings, the combination of clinical quality, rapid access, and significant cost savings has made China a serious option for patients worldwide. Each medical situation is unique, and outcomes depend on individual health factors, disease stage, and adherence to post-treatment care. Prospective patients are encouraged to research thoroughly — verifying hospital accreditations, surgeon credentials, and treatment costs — before making any decisions.

Disclaimer: Individual results vary. Medical outcomes depend on many factors including the patient’s overall health, disease stage, and adherence to post-treatment care. Cost estimates are based on published pricing at the time of writing and may vary. Always consult with qualified medical professionals for personalized medical advice.

Article by myMedVia — Your Trusted Partner for Medical Travel to China